Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,567	5,280	3,348	2,186	2,097	3,039
Market Cap Growth	57.69%	57.69%	53.13%	4.24%	-30.98%	119.78%
Enterprise Value	5,970	4,739	2,933	1,787	1,603	2,598
Last Close Price	62.24	50.39	32.48	20.31	19.80	26.16
PE Ratio	50.60	37.78	31.74	21.59	18.64	28.67
Forward PE	36.72	32.11	32.61	19.95	21.01	32.91
PS Ratio	9.52	7.82	6.94	5.44	5.73	8.59
PB Ratio	9.63	7.77	6.61	4.36	5.58	5.81
P/TBV Ratio	9.66	7.77	6.61	4.36	5.58	5.81
P/FCF Ratio	33.52	26.95	26.38	18.23	12.53	20.16
P/OCF Ratio	33.15	26.66	26.36	18.17	12.49	20.00
PEG Ratio	-	-	-	-	1.50	-
EV/Sales Ratio	8.84	7.02	6.08	4.45	4.38	7.34
EV/EBITDA Ratio	43.34	34.40	27.08	15.69	12.73	20.18
EV/EBIT Ratio	43.59	34.60	27.34	15.87	12.88	20.26
EV/FCF Ratio	30.48	24.19	23.12	14.90	9.58	17.24
Debt / Equity Ratio	0.01	0.01	0	0.00	0.00	0.01
Debt / EBITDA Ratio	0.05	0.05	0.00	0.01	0.00	0.02
Debt / FCF Ratio	0.04	0.04	0.00	0.01	0.00	0.02
Asset Turnover	0.92	0.92	0.80	0.80	0.74	0.72
Inventory Turnover	1.08	1.08	0.94	0.97	1.07	1.08
Quick Ratio	3.11	3.11	4.05	6.60	5.31	9.86
Current Ratio	3.35	3.35	4.39	6.89	5.61	10.07
Return on Equity (ROE)	23.81%	23.81%	21.05%	23.11%	25.03%	23.70%
Return on Assets (ROA)	11.71%	11.71%	11.13%	13.98%	15.63%	16.29%
Return on Capital (ROIC)	14.34%	14.34%	13.28%	16.01%	17.25%	17.79%
Return on Capital Employed (ROCE)	19.60%	19.60%	20.80%	22.00%	33.10%	24.50%
Earnings Yield	212.80%	2.67%	3.17%	4.64%	5.36%	3.49%
FCF Yield	298.32%	3.71%	3.79%	5.48%	7.98%	4.96%
Buyback Yield / Dilution	-155.50%	-1.55%	3.64%	7.94%	-1.42%	-1.33%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q